Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Announcement

· NSE Neutral
📢 Key Event
Jagsonpal to acquire 85% stake in Aequitas Healthcare
🔮 What's Next
concluded by 15th July, 2026
💡 Investor Takeaway
The acquisition provides Jagsonpal with a ready platform to enter the hospital segment, which now contributes ~10% of pharma industry sales and is growing faster.

Jagsonpal Pharmaceuticals announced it will acquire an 85% stake in Aequitas Healthcare Private Limited for Rs. 20.8 crores, marking its strategic entry into the hospital segment and expanding its presence in India's growing healthcare ecosystem.

📄 View Original Announcement (PDF)

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,384.48 Cr P/E: 32.1

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day